• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

索利那新引起的意识混乱和幻觉。

Solifenacin-induced delirium and hallucinations.

机构信息

Ormoz Psychiatric Hospital, Department for Clinical Pharmacy, Slovenia, Ptujska Cesta 33, Ormoz, Slovenia.

出版信息

Gen Hosp Psychiatry. 2013 Nov-Dec;35(6):682.e3-4. doi: 10.1016/j.genhosppsych.2013.06.002. Epub 2013 Jul 15.

DOI:10.1016/j.genhosppsych.2013.06.002
PMID:23866158
Abstract

Solifenacin-induced cognitive adverse effects have not been reported frequently, but solifenacin-induced delirium and hallucinations with successful switching to darifenacin, without additional drug, have not been reported in the literature. In this case report, we present an 80-year-old Caucasian male with insomnia and anxiety symptoms and overactive bladder who developed delirium and hallucinations when treated with solifenacin and trazodone. After solifenacin discontinuation and switching to darifenacin, symptoms significantly improved immediately. Such a case has not yet been described in literature; however, an adverse effect associated with solifenacin can occur, as this report clearly demonstrates.

摘要

索利那新引起的认知不良反应并不常见,但文献中尚未报道过索利那新引起的谵妄和幻觉,而改用达非那新后无需加用其他药物即可缓解。在本病例报告中,我们介绍了一位 80 岁的白人男性,他因失眠和焦虑症状以及膀胱过度活动症而接受索利那新和曲唑酮治疗,随后出现了谵妄和幻觉。停止使用索利那新并改用达非那新后,症状立即显著改善。这种情况在文献中尚未描述;然而,正如本报告清楚表明的那样,索利那新可能会出现不良反应。

相似文献

1
Solifenacin-induced delirium and hallucinations.索利那新引起的意识混乱和幻觉。
Gen Hosp Psychiatry. 2013 Nov-Dec;35(6):682.e3-4. doi: 10.1016/j.genhosppsych.2013.06.002. Epub 2013 Jul 15.
2
Comparison of two selective muscarinic receptor antagonists (solifenacin and darifenacin) in women with overactive bladder--the SOLIDAR study.两种选择性毒蕈碱受体拮抗剂(索利那新和达非那新)用于膀胱过度活动症女性的比较——SOLIDAR研究
Coll Antropol. 2012 Dec;36(4):1347-53.
3
Solifenacin-induced small bowel pseudo-obstruction.索利那新诱发的小肠假性梗阻。
J Hosp Med. 2008 Mar;3(2):176-8. doi: 10.1002/jhm.269.
4
QT prolongation and torsade de pointes associated with solifenacin in an 81-year-old woman.一名81岁女性使用索利那新后出现QT间期延长及尖端扭转型室性心动过速
Br J Clin Pharmacol. 2008 Dec;66(6):896-7. doi: 10.1111/j.1365-2125.2008.03298.x.
5
The efficacy and safety of solifenacin in patients with overactive bladder syndrome.索利那新治疗膀胱过度活动症患者的疗效和安全性。
Coll Antropol. 2012 Mar;36(1):243-8.
6
Solifenacin succinate (VESIcare): overactive bladder therapy.琥珀酸索利那新(卫喜康):膀胱过度活动症治疗药物。
Urol Nurs. 2006 Dec;26(6):496-7.
7
Effects of solifenacin on overactive bladder symptoms, symptom bother and other patient-reported outcomes: results from VIBRANT - a double-blind, placebo-controlled trial.索利那新对膀胱过度活动症症状、症状困扰和其他患者报告结局的影响:来自 VIBRANT 的双盲、安慰剂对照试验结果。
Int J Clin Pract. 2009 Dec;63(12):1702-14. doi: 10.1111/j.1742-1241.2009.02209.x.
8
Symptom bother and health-related quality of life outcomes following solifenacin treatment for overactive bladder: the VESIcare Open-Label Trial (VOLT).索利那新治疗膀胱过度活动症后的症状困扰及健康相关生活质量结局:卫喜康开放标签试验(VOLT)
Clin Ther. 2006 Nov;28(11):1935-46. doi: 10.1016/j.clinthera.2006.11.010.
9
Randomized, double-blind, placebo- and propiverine-controlled trial of the once-daily antimuscarinic agent solifenacin in Japanese patients with overactive bladder.在日本膀胱过度活动症患者中进行的每日一次抗毒蕈碱药物索利那新的随机、双盲、安慰剂和丙哌维林对照试验。
BJU Int. 2007 Sep;100(3):579-87. doi: 10.1111/j.1464-410X.2007.07031.x.
10
Tolerability of solifenacin and oxybutynin immediate release in older (> 65 years) and younger (≤ 65 years) patients with overactive bladder: sub-analysis from a Canadian, randomized, double-blind study.索利那新和奥昔布宁速释制剂在老年(>65 岁)和年轻(≤65 岁)膀胱过度活动症患者中的耐受性:来自加拿大一项随机、双盲研究的亚分析。
Curr Med Res Opin. 2011 Feb;27(2):375-82. doi: 10.1185/03007995.2010.541433. Epub 2010 Dec 23.

引用本文的文献

1
Case Report: Synergistic central nervous system depression of baclofen and pregabalin: clinical pharmacist-driven case analysis and case review.病例报告:巴氯芬与普瑞巴林协同导致中枢神经系统抑制:临床药师主导的病例分析与病例回顾
Front Pharmacol. 2025 Jun 5;16:1598971. doi: 10.3389/fphar.2025.1598971. eCollection 2025.
2
Case Report: Potential of pharmacological treatment for auditory abnormal sensations with aripiprazole: a report of two cases.病例报告:阿立哌唑治疗听觉异常感觉的药理学潜力:两例报告
Front Psychiatry. 2025 Jun 3;16:1614500. doi: 10.3389/fpsyt.2025.1614500. eCollection 2025.
3
Solifenacin-induced acute psychosis: a case report.
索利那新诱发的急性精神病:一例报告
Gen Psychiatr. 2021 Oct 12;34(5):e100586. doi: 10.1136/gpsych-2021-100586. eCollection 2021.
4
Mirabegron in the Treatment of Overactive Bladder: Safety and Efficacy in the Very Elderly Patient.米拉贝隆治疗膀胱过度活动症:高龄患者的安全性和疗效。
Clin Interv Aging. 2020 Apr 23;15:575-581. doi: 10.2147/CIA.S174402. eCollection 2020.
5
Anticholinergics for Overactive Bladder in Frail and Medically Complex Older People: The Case For.抗胆碱能药物用于体弱且患有多种疾病的老年人膀胱过度活动症:支持理由
Drugs Aging. 2018 Sep;35(9):777-780. doi: 10.1007/s40266-018-0577-8.
6
Delirium following fesoterodine treatment for urgency incontinence in an 89-year old man.一名89岁男性在使用非索非那定治疗急迫性尿失禁后出现谵妄。
Can Urol Assoc J. 2016 Jul-Aug;10(7-8):E261-E263. doi: 10.5489/cuaj.3697. Epub 2016 Jul 12.
7
Managing Urinary Incontinence in Patients with Dementia: Pharmacological Treatment Options and Considerations.痴呆患者尿失禁的管理:药物治疗选择与注意事项
Drugs Aging. 2015 Jul;32(7):559-67. doi: 10.1007/s40266-015-0281-x.
8
Excessive sweating induced by interaction between agomelatine and duloxetine hydrochloride: case report and review of the literature.阿戈美拉汀与盐酸度洛西汀相互作用引起多汗症:病例报告及文献复习
Wien Klin Wochenschr. 2015 Sep;127(17-18):703-6. doi: 10.1007/s00508-014-0688-0. Epub 2015 Jan 10.